Ransomware group behind cyberattack: Sun Pharma
A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal.
The US FDA plans to permit the use of salt substitutes in daily food, such as bread, cheeses and ketchup, to reduce the.
Smokers may benefit from Sanofi's asthma drug after a phase III trial showed "significant improvements in lung function, quality of life" and uncontrolled.
The pill, revumenib, has shown benefit in treating both adults and children with certain type of acute leukemia.
BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.
An estimated 40,000 Somalians may have died last year in a drought caused by the failure of six consecutive rainy seasons, a new.
About 800,000 people die yearly from diseases directly linked to unsafe water, inadequate sanitation, poor hygiene practices, and water-related hazards have increased at.
The WHO’s scientific advisors have called on China to release all data relating to the COVID-19 origins after a new report hinted at.
India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of.
The FDA’s advisory panel recommended full approval of Pfizer’s Covid antiviral treatment Paxlovid for high-risk adults.